Skip to main content
. 2009 Jul 6;14(8):2151–2161. doi: 10.1111/j.1582-4934.2009.00844.x

Fig 8.

Fig 8

Scriptaid decreases telomerase activity in glioma cells in a JNKindependent manner. Treatment with scriptaid decreases telomerase activity of glioma cells. Glioma cells were treated with 20 μM scriptaid in the presence or absence of 20 μM JNK inhibitor SP600125, and TeloTAGGG Telomerase PCR ELISA was performed. The decrease in telomerase activity observed in scriptaid-treated cells was unaffected by JNK inhibitor. Values represent the means ± SEM from three independent experiments. *Significant decrease from control (P≤ 0.05).